# The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment

> **NCT00372372** · PHASE4 · COMPLETED · sponsor: **Tuen Mun Hospital** · enrollment: 120 (—)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** risedronate

## Key facts

- **NCT ID:** NCT00372372
- **Lead sponsor:** Tuen Mun Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 120 (—)
- **Last updated:** 2007-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372372, "The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00372372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*